NLM Logo

tucatinib MeSH Supplementary Concept Data 2024


MeSH Supplementary
tucatinib
Unique ID
C000705452
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000705452
Entry Term(s)
N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine
N6-(4,5-dihydro-4,4-dmethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-A)pyridin-7-Yloxy)phenyl)-4,6-quinazolinediamine
ONT-380
irbinitinib
tukysa
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Number
234248D0HH
Heading Mapped to
*Oxazoles
*Pyridines
*Quinazolines
Frequency
44
Note
receptor tyrosine kinase inhibitor for tratment of HER2 positive breast cancer
Source
N Engl J Med. 2020 Feb 13;382(7):597-609.
Date of Entry
2020/04/17
Revision Date
2021/11/24
tucatinib Preferred
N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine Broader
page delivered in 0.007s